Esquire Financial vs NewtekOne
ESQ and NEWT side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ESQ and NEWT compare
Esquire Financial is the larger company, worth 5.3 times as much as NewtekOne ($1.6B against $296M).
On earnings, NewtekOne is cheaper: it trades at 4.7× trailing earnings, against 21.2× for Esquire Financial.
Esquire Financial grew revenue faster over the last twelve months (18.6% versus 7.1% for NewtekOne).
Esquire Financial keeps more of each dollar of sales as profit, with a net margin of 33.0% compared with 22.2% at NewtekOne.
Both pay dividends: Esquire Financial yields 0.62% and NewtekOne 7.4%.
NewtekOne scores higher on the StockData Score (20 against 14 for Esquire Financial), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ESQ | NEWT |
|---|---|---|
| Size and price | ||
| Market cap | $1.6B | $296M |
| Share price | $128.74 | $10.25 |
| Change, 1 year | 31.5% | 2.0% |
| Change, 5 years | 267% | −65.6% |
| Beta (5Y) | 0.37 | 1.18 |
| Employees | 151 | 109 |
| StockData Score | ||
| Total score | 14 | 20 (better) |
| Valuation score | 0 | 6 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 5 (better) | 3 |
| Health score | 3 | 5 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 21.2× | 4.7× (better) |
| P/S | 9.8× | 1.0× (better) |
| P/B | 5.0× | 0.7× (better) |
| P/FCF | 23.5× | – |
| PEG | 1.11 | 0.26 (better) |
| FCF yield | 4.3% (better) | −250% |
| Fair value | $64.35 | $18.98 |
| Margin of safety | −100% | 46.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 18.6% (better) | 7.1% |
| Revenue growth, 5Y average | 23.0% | – |
| Net income growth (TTM) | 13.6% | 22.7% (better) |
| EPS growth (TTM) | 12.0% (better) | 9.5% |
| EPS growth, 5Y average | 28.9% | – |
| Profitability | ||
| Net margin | 33.0% (better) | 22.2% |
| FCF margin | 41.6% (better) | −251% |
| Return on equity | 18.3% (better) | 18.0% |
| Financial health | ||
| Altman Z-score | 0.61 (better) | 0.20 |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Dividend yield | 0.62% | 7.4% (better) |
| Payout ratio | 12.1% | 46.6% |
| Years of dividend growth | 3 (better) | 0 |
| Shareholder yield | 0.62% | 7.4% (better) |
| Ownership | ||
| Held by institutions | 52.7% | 55.7% |
| Held by insiders | 11.6% | 17.2% |
| Insider net buying, 12 months | −$9.1M | $434K (better) |
| Short interest, % of float | 11.8% | – |
Go deeper
- ESQ stock overview
- ESQ income statement
- ESQ valuation and score
- NEWT stock overview
- NEWT income statement
- NEWT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.